Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Pediatr Endocrinol Metab. 2011;24(3-4):169–174. doi: 10.1515/jpem.2011.092

Figure 1.

Figure 1

Bar graph of the percent of individuals with specific levels (intervals of 4 ng/ml) of 25OHD concentrations within each neurofibromatosis type 1 (NF1) and control group. Black bars represent control individuals and white bars represent individuals with NF1.